Skip to main content
Search

Or 34,00 After 66% tax deduction

I make a monthly donation I make an IFI donation
Institutional

New European alliance formed to tackle urgent challenge of neurodegenerative diseases

Last update: 22/09/2025 Reading time: 1 min
logo CURE ND
Retour à la recherche

Top research institutes from Germany, France, Belgium and the UK have formed a new alliance to combat neurodegenerative diseases. Their mission? Catalysing a United Response in Europe to Neurodegenerative Diseases, or CURE-ND for short.

Neurodegenerative diseases, such as Alzheimer’s disease and Parkinson’s disease, affect millions of people globally, with a significant impact on individuals, families, economies and wider society. Worldwide, around 50 million people have some form of dementia, and there are nearly 10 million new cases every year. Finding ways to prevent, treat and cure neurodegeneration is one of today’s most urgent medical needs.

Leading neuroscientists from four top European research institutes believe that collaboration is the best way forward to meet this challenge. The German Centre for Neurodegenerative Diseases (DZNE), the Paris Brain Institute, Mission Lucidity in Belgium and the UK Dementia Research Institute have committed to share expertise and present a strong united voice to champion brain research and put an end to historic underfunding of the field in Europe.

Prof. Pierluigi Nicotera, Scientific Director of DZNE: “The added value of connecting the major European organizations that conduct research into neurodegeneration has become increasingly clear in recent years.” A new alliance is now born: CURE-ND. “With CURE-ND, we want to catalyse a united response in Europe to tackle these diseases.”

“Together, we represent a critical mass of more than 2000 researchers”, adds Prof. Alexis Brice, Director General of the Paris Brain Institute. “We have clear synergies and complementarities among our centres, which should allow a very efficient and powerful response. Our alliance embraces a joint effort to accelerate the pace of scientific discovery and nurture breakthroughs in the field of neurodegenerative diseases.”

Prof. Dr. Mathieu Vandenbulcke, Scientific Chairman of Mission Lucidity: “Our ambitious initiative ranges from uncovering disease mechanisms to improving clinical care. CURE-ND will facilitate the development and global implementation of neurotechnologies that enhance care for today’s and tomorrow’s patients.”

Besides bringing together excellent science to accelerate research and improve clinical care, CURE-ND aims to raise global awareness of the need to urgently address the challenge of neurodegenerative diseases, and to lobby for the necessary funding to be committed to research in this area. The partners are calling for a long-term vision and funding of brain research by Europe.

“Collaborating across borders to address neurodegeneration is more important than ever. With the ongoing pandemic, budget cuts in Horizon Europe and uncertainty around Brexit, I’m proud that these leading institutes are taking responsibility for driving forward much-needed progress. Now is the time to pull together, not pull apart”, concludes Prof. Bart De Strooper, Director of the UK Dementia Research Institute.

Our news on the subject

L’Institut du Cerveau renforce son engagement en faveur de la santé cérébrale en Afrique subsaharienne
Paris Brain Institute strengthens its commitment to advancing brain health and research capacity in Sub-Saharan Africa
A first international course on epidemiology, neuroepidemiology and vascular neurology held in Benin
10.07.2025 Institutional
Serge Weinberg © Simon Cassanas
Serge Weinberg appointed Chairman of Paris Brain Institute Board of Directors
Paris Brain Institute announces Serge Weinberg’s election as President of its Board of Directors. He succeeds Gérard Saillant, our Founding President, who becomes Honorary President after fifteen years of dedicated service to the Institute.
10.16.2025 Institutional
Visuel Voeux 2025
2025: An ambitious dynamic led by Prof. Stéphanie DEBETTE, the new Executive Director of the Institute since January 1, 2025
Professor Gérard SAILLANT, President of Paris Brain Institute, extends his warmest wishes to all those who, by faithfully supporting the research carried out at the institute, enable us to make a tangible difference in our fight against brain...
01.08.2025 Institutional
Stéphanie Debette
Professor Stéphanie Debette takes the helm of Paris Brain Institute
Appointed Executive Director of Paris Brain Institute for a five-year term, Professor Stéphanie Debette took up her new position on January 1, 2025. She succeeds Professor Alexis Brice, who has served as Executive Director since 2012.
01.07.2025 Institutional
L'IRM 7 Tesla à l’Institut du Cerveau
A 7-Tesla MRI scanner at Paris Brain Institute: cutting-edge technology at the service of scientific ambition
This week, Paris Brain Institute inaugurated an exceptional piece of equipment: the latest generation 7-Tesla MAGNETOM Terra.X MRI scanner from Siemens Healthineers. This acquisition, made possible thanks to the support of RICHARD MILLE and the...
11.28.2024 Institutional
Les participants du Dîner annuel de Paris Brain Institute America
Annual Dinner of Paris Brain Institute America at the French Consulate in New York – A Resounding Success for Neuroscience Research
On October 8, 2024, the French Consulate in New York hosted the annual dinner of Paris Brain Institute America (PBIA), gathering prominent philanthropists and influential figures from the scientific community for an evening dedicated to transatlantic...
10.15.2024 Support
See all our news